Home

EOCN

Neutral

Eocene Ltd.

Healthcare·Biotechnology

$4.01

Current Price

$38.5M

Market Cap

—

P/E Ratio

$7.45

52W High

$2.8

52W Low

Company Profile

CEO

Executive Leadership

Employees

25

Year Founded

2021

Headquarters

United States

Sector / Industry

Healthcare · Biotechnology

Key Statistics

Market Cap

$38.5M

Today's High

$4.08

Today's Low

$3.95

Open

$4.03

Previous Close

$3.84

52-Week High

$7.45

52-Week Low

$2.80

Today's Volume

11.2K

Avg. Volume

35.2K

Overnight Volume

1.5K

Shares Outstanding

9.6M

P/E Ratio

0.00

EPS

$-2.32

Beta

1.42

Dividend Yield

0.00%

Live market stats are a premium feature

These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.

Earnings History

Quarterly expected vs. actual performance

Q1 20262026-05-14
Missed -11%
EPS Est.-0.65
EPS Actual-0.72
Rev. Est.$0.00M
Rev. Actual$0.00M
Q4 20252026-03-26
Missed -5%
EPS Est.-0.58
EPS Actual-0.61
Rev. Est.$0.00M
Rev. Actual$0.00M
Q3 20252025-11-13
Beat 6%
EPS Est.-0.52
EPS Actual-0.49
Rev. Est.$0.00M
Rev. Actual$0.00M
Q2 20252025-08-14
Beat 0%
EPS Est.-0.50
EPS Actual-0.50
Rev. Est.$0.00M
Rev. Actual$0.00M

Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.

Historical Price Chart

Price History

Chart data unavailable

AI Price Targets

Eocene Ltd. (EOCN) trades around $4.01 with low market liquidity and ongoing negative earnings per share common to clinical-stage biotech and early development firms. Technical momentum remains neutral following recent pullbacks, with price action consolidating between $3.50 support and $4.50 resistance.

7-Day Target

$4.15

+3.5%

30-Day Target

$4.50

+12.2%

6-Month Target

$5.20

+29.7%

AI Confidence

58%

Risk Level

High

Analyst Target

$18.5

Bull Case

EHang is uniquely positioned as a first-mover in the eVTOL market with its EH216-S obtaining type certification, creating a significant barrier to entry for competitors. Success in commercial operations across China and expansion into international markets could lead to rapid revenue scaling.

Bear Case

Stringent regulatory hurdles and safety concerns regarding urban autonomous flight could delay mass adoption indefinitely. Additionally, significant capital burn and potential dilution pose long-term risks to shareholder value.

Key Catalysts

  • Expansion of commercial flight operations in pilot cities
  • Additional international airworthiness certifications
  • Government subsidies for low-altitude economy infrastructure
  • Successful execution of multi-passenger vehicle testing

Key Risks

  • •Regulatory approval delays in key international markets
  • •High cash burn rate impacting liquidity
  • •Intense competition from emerging aerospace and automotive incumbents
  • •Public skepticism regarding the safety of autonomous passenger flight

Company Overview

EHang Holdings Limited is a pioneer in the autonomous aerial vehicle (AAV) technology industry, focusing on urban air mobility solutions. The company develops passenger-grade and logistics AAVs designed for safe and efficient autonomous flight.

Take this research further — free

Open EOCN in the full AI tools and run your own analysis: live charts, 7-day to 6-month targets, and risk checks. 15 minutes free, no card required.

Rather have it all, permanently?

30-day money-back guarantee • Secure payment by Square

EOCN Stock FAQ

What is the AI analysis for EOCN stock?

Stockinhood's AI generates multi-timeframe price targets for EOCN (Eocene Ltd.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.

Is EOCN stock a good investment?

Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to EOCN based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Neutral. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.

What is the price target for EOCN?

The AI-generated price target for EOCN is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $4.01. Price targets are educational estimates and should not be relied upon for investment decisions.

What are the risks of investing in EOCN?

Regulatory approval delays in key international markets High cash burn rate impacting liquidity Intense competition from emerging aerospace and automotive incumbents Public skepticism regarding the safety of autonomous passenger flight All risk analysis is informational only and not financial advice.

What sector is EOCN in?

Eocene Ltd. (EOCN) operates in the Healthcare sector, specifically the Biotechnology industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.